Joby Surges on Q1 Beat and Certification Milestones, but Key Gating Items Remain

What happened

Joby Aviation surged on May 6 after reporting better-than-expected Q1 results and providing evidence of advancing FAA certification, including first flights of its conforming aircraft and New York point-to-point tests. The Q1 beat showed revenue of $24.2M from Blade operations, while net loss of $110M was slightly narrower than expected, and liquidity was fortified to ~$2.5B after a large capital raise. Despite the positive headlines, the company remains deep in the red with R&D spending of $177.5M, and the path to profitability hinges on completing FAA stage four and securing Toyota's manufacturing alliance. The market is pricing in continued regulatory progress, but filings reveal schedule fragility—a major airworthiness milestone was completed after the PSU deadline, and the Toyota agreement is not yet contracted. With the stock at $10.52, near the top of its valuation range per the master report, the surge reflects optimism about certification milestones but leaves little margin of safety.

Implication

Investors should recognize that the Q1 beat and flight tests are positive but expected; the stock's move to $10.52 now prices in a high probability of certification success without the confirmation of key gating items. The master report's base case value is $11, leaving limited upside from here, while downside to $7 is possible if certification stalls. The next 3-6 months require observable progress: FAA pilots flying for credit and a signed Toyota Strategic Alliance Agreement. Without those, the risk-reward skews negative. Patience is warranted; wait for either a pullback toward $8.50 or explicit confirmation of these milestones.

Thesis delta

The Q1 beat and clearer path to passenger flights reduce near-term timeline risk slightly, but the two gating items—FAA for-credit flights and Toyota alliance—remain unconfirmed. The thesis shifts from 'wait for confirmation' to 'sell into strength' as the stock now prices in optimistic assumptions without validation.